Zobrazeno 1 - 10
of 13
pro vyhledávání: '"V Vazquez-Vela"'
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Occupational exposure to hazardous drugs (HD) can cause damage to health in exposed healthcare professionals, so protective measures must be taken. Aim and objectives To identify HD included in the pharmacotherapeutic guide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc0b689039fa06b90906d9b20fd88122
https://doi.org/10.1136/ejhpharm-2020-eahpconf.302
https://doi.org/10.1136/ejhpharm-2020-eahpconf.302
Autor:
Mdv Sanchez Matamoros Piazza, V Vazquez Vela, A Varas Pérez, C Puivecino Moreno, C Mora Herrera
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance The incidence and severity of cases of Clostridium difficile infection (CDI) has been increasing, as well as hospital stays and hospitalisation costs. Aim and objectives To analyse the therapeutic approach of CDI and the con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2187577ffec29d99fc77ae4f702005eb
https://doi.org/10.1136/ejhpharm-2020-eahpconf.425
https://doi.org/10.1136/ejhpharm-2020-eahpconf.425
Autor:
C Mora Herrera, V Sanchez-Matamoros Piazza, V Vazquez-Vela, A Varas-Perez, C Puivecino Moreno
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Malnutrition and/or involuntary weight loss increases the risk of mortality and disability, decreasing quality of life. Nutritional status is an independent predictor of mortality per year, especially in the institutionalise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5c58243de6b2e6cbcb8b5c072f0c2c3
https://doi.org/10.1136/ejhpharm-2020-eahpconf.303
https://doi.org/10.1136/ejhpharm-2020-eahpconf.303
Autor:
JF Sierra Sánchez, R Gavira Moreno, P Gómez Germá, A Varas Pérez, V Vazquez Vela, C Puivecino Moreno
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Drug management of haematological patients is complex because it integrates numerous agents (antineoplastics, supportive care and medications for comorbidities). In the ambulatory setting, the clinical pharmacist can contrib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1656a090f93d4a505e4a68e23a53e546
https://doi.org/10.1136/ejhpharm-2020-eahpconf.197
https://doi.org/10.1136/ejhpharm-2020-eahpconf.197
Autor:
V Vazquez-Vela, C Cuadros Martinez, MT Leal-Macias, C Puivecino Moreno, V Sanchez-Matamoros-Piazza
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Prolongation of the QT interval in the ECG can trigger an arrhythmia (torsades de pointes) that usually resolves spontaneously, although sometimes it can cause ventricular fibrillation and sudden death. Drugs are a frequent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32ae5c4ec0bf1e59a7317dc2cc72d3c0
https://doi.org/10.1136/ejhpharm-2020-eahpconf.330
https://doi.org/10.1136/ejhpharm-2020-eahpconf.330
Autor:
R Gavira Moreno, A Varas Pérez, JF Sierra Sánchez, L Jiménez Pichardo, R Gázquez Pérez, A Alcala Soto, MT Gómez de Travecedo y Calvo, V Sanchez-Matamoros Piazza, C Puivecino Moreno, V Vazquez Vela
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background In long-term safety studies of sunitinib, most adverse events (AE) occurred initially between the first 6 months and 1 year, and remained stable or decreased in frequency over time. Purpose To analyse the safety and tolerability of sunitin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c25231f56d6a73d152df3ba61263132
https://doi.org/10.1136/ejhpharm-2019-eahpconf.478
https://doi.org/10.1136/ejhpharm-2019-eahpconf.478
Publikováno v:
Eur J Hosp Pharm
BackgroundImproving the quality of drug prescriptions is part of the corporate objectives of health systems. Finding the correlation between the quality of the prescription measured through a synthetic quality indicator (SIQ) and the prevalence of po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf835d743769d2ea1633441aa9037a1e
https://doi.org/10.1136/ejhpharm-2018-eahpconf.463
https://doi.org/10.1136/ejhpharm-2018-eahpconf.463
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J González-Miret Martín, MJ Gutiérrez Fernández, V Vazquez Vela, E Guerrero Serrano, E Moreno Campoy, M Pajares Alonso, M Zaragoza Rascón
Publikováno v:
European Journal of Hospital Pharmacy. 22:A77.1-A77
Background Enzyme Replacement Therapy (ERT) is the current standard treatment which significantly improves the quality of life of patients with type-1 Gaucher’s Disease (GD-1). Purpose To evaluate the use of ERT in patients with GD-1. Material and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8a488aa9e46a6be8126218837f8406d
https://doi.org/10.1136/ejhpharm-2015-000639.184
https://doi.org/10.1136/ejhpharm-2015-000639.184
Autor:
MJ Huertas Fernandez, L Obel Gil, MJ Martinez Bautista, MV Manzano Martin, V Vazquez Vela, JM Rodriguez Camacho
Publikováno v:
European Journal of Hospital Pharmacy. 19:133.1-133
Background Pharmaceutical care(PC) is the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient9s quality of life. Purpose To analyse the results of a PC program in patients who are infected with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e1b32564177b0535fc322336a3ab7e8
https://doi.org/10.1136/ejhpharm-2012-000074.127
https://doi.org/10.1136/ejhpharm-2012-000074.127